A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine.

Autor: Latzer P; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Zelba H; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Battke F; CeGaT GmbH, Tübingen, Germany., Reinhardt A; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Shao B; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Bartsch O; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Rabsteyn A; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Harter J; CeGaT GmbH, Tübingen, Germany., Schulze M; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Okech T; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany., Golf A; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany., Kyzirakos-Feger C; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Kayser S; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Pieper N; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Feldhahn M; CeGaT GmbH, Tübingen, Germany., Wünsche J; Zentrum für Humangenetik Tübingen, Tübingen, Germany.; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany., Seitz C; Universitätsklinikum Heidelberg, KiTZ, Hopp Children's Cancer Center, Heidelberg, Germany., Hadaschik D; CeCaVa GmbH, Tübingen, Germany., Garbe C; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Hauser TK; Department für Radiologie, Universitätsklinikum Tübingen, Tübingen, Germany., la Fougère C; Nuklearmedizin und Klinische Molekulare Bildgebung, Universitätsklinikum Tübingen, Tübingen, Germany., Biskup D; CeGaT GmbH, Tübingen, Germany., Brooke D; Provenance Precision Medicine Foundation, Wilmette, IL, USA., Parker D; PHM, Los Angeles, CA, USA., Martens UM; Department of Hematology and Oncology, Cancer Center Heilbronn-Franken, SLK Kliniken GmbH, Heilbronn, Germany., Illerhaus G; Klinikum Stuttgart, Stuttgart, Germany., Blumenthal DT; Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel Aviv, Israel., Merrell R; Vanderbilt University Medical Center, Nashville, TN, USA., Lorenzo LS; Clínica Universidad de Navarra, Madrid, Spain., Hidvégi M; Jewish Theological Seminary-University of Jewish Studies (OR-ZSE), Budapest, Hungary., de Robles P; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.; Tom Baker Cancer Centre, Calgary, AB, Canada., Kebir S; Universitätsklinikum Essen, Essen, Germany., Li WW; Angiogenesis Foundation, Cambridge, MA, USA., Li VW; Angiogenesis Foundation, Cambridge, MA, USA.; Harvard Medical School Dermatology, Boston, MA, USA., Williams M; NHS London, London, UK., Miller AM; Brain and Spine Tumor Center, NYU Langone Health's Perlmutter Cancer Center, New York, NY, USA., Kesari S; Pacific Neuroscience Institute, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Castro M; Cellworks Group Inc, South San Francisco, CA, USA.; Personalized Cancer Medicine, PLLC, Santa Monica, CA, USA., Desjardins A; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Ashley DM; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Preston Robert Tisch Brain Tumor Centre, Duke University, Durham, NC, USA., Friedman HS; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Neil EC; Department of Neurology, University of Minnesota Health, Minneapolis, MN, USA., Iwamoto FM; Columbia University Medical Center, New York, NY, USA., Sipos B; BAG für Pathologie und Molekularpathologie Stuttgart, Molekularpathologie Baden-Württemberg GbR, Stuttgart, Germany., Geletneky K; Klinikum Darmstadt GmbH, Darmstadt, Germany., Zender L; University Hospital Tübingen, Internal Medicine VIII, Tübingen, Germany., Glas M; Division of Clinical Neurooncology, Department of Neurology, Universitätsklinikum Essen Klinik für Neurologie, Essen, Germany., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Biskup S; Zentrum für Humangenetik Tübingen, Tübingen, Germany. Saskia.Biskup@humangenetik-tuebingen.de.; CeGaT GmbH, Tübingen, Germany. Saskia.Biskup@humangenetik-tuebingen.de.

Publikováno v: Nature communications [Nat Commun] 2024 Aug 11; Vol. 15 (1), pp. 6870. Date of Electronic Publication: 2024 Aug 11.

[Older adults in the first year of the COVID-19 pandemic: health-related findings of the German Ageing Survey (DEAS)].

Autor: Wünsche J; Deutsches Zentrum für Altersfragen, Manfred-von-Richthofen-Str. 2, 12101, Berlin, Deutschland. jenna.wuensche@dza.de., Spuling SM; Deutsches Zentrum für Altersfragen, Manfred-von-Richthofen-Str. 2, 12101, Berlin, Deutschland., Nowossadeck S; Deutsches Zentrum für Altersfragen, Manfred-von-Richthofen-Str. 2, 12101, Berlin, Deutschland., Stuth S; Deutsches Zentrum für Altersfragen, Manfred-von-Richthofen-Str. 2, 12101, Berlin, Deutschland.

Publikováno v: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz [Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz] 2023 Mar; Vol. 66 (3), pp. 232-240. Date of Electronic Publication: 2023 Jan 25.

Middle-aged and older adults' psychosocial functioning trajectories before and during the COVID-19 pandemic: Evidence for multidirectional trends.

Autor: Wettstein M; Department of Psychology, Developmental and Educational Psychology, Humboldt University of Berlin., Spuling SM; German Centre of Gerontology., Wünsche J; German Centre of Gerontology., Henning G; German Centre of Gerontology.

Publikováno v: Psychology and aging [Psychol Aging] 2023 Nov; Vol. 38 (7), pp. 627-643. Date of Electronic Publication: 2023 Jun 22.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.